Short Interest in Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) Decreases By 99.0%

Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 100 shares, a decrease of 99.0% from the February 29th total of 9,900 shares. Based on an average daily trading volume, of 37,700 shares, the days-to-cover ratio is currently 0.0 days.

Mydecine Innovations Group Stock Down 35.4 %

MYCOF stock traded down $0.01 during mid-day trading on Thursday, reaching $0.01. 7,882 shares of the stock traded hands, compared to its average volume of 26,468. Mydecine Innovations Group has a 52 week low of $0.00 and a 52 week high of $0.66. The business has a 50-day moving average of $0.01 and a two-hundred day moving average of $0.05.

About Mydecine Innovations Group

Mydecine Innovations Group Inc, a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004.